13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SC Filed 2022-09-16 Event — SEC 0001193125-22-246283 →

Novo Holdings A/S Edgewise Therapeutics, Inc. EWTX

Stake: Shares:

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
2 13D/G filings on this issuer
1 other filing besides this one
Filer Track Record
35 filings by this filer
34 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 11.83
9,448,351 shares short · -0.3% vs prior

Other 13D/G Filings on Edgewise Therapeutics, Inc.

FiledFormFilerStakeShares
2022-09-16 SC ORBIMED ADVISORS LLC view →

Other Filings by Novo Holdings A/S

FiledFormIssuerStakeShares
2026-01-23 SCHEDULE IO Biotech, Inc. IOBTQ 3.30% 2,469,135 view →
2025-01-16 SCHEDULE Galecto, Inc. DMRA 7.60% 99,913 view →
2024-03-18 SC SPRUCE BIOSCIENCES, INC. SPRB view →
2024-01-02 SC Rallybio Corp RLYB view →
2023-08-11 SC IO Biotech, Inc. IOBTQ view →
2023-06-06 SC LAVA Therapeutics NV view →
2023-02-24 SC LAVA Therapeutics NV view →
2023-02-21 SC SPRUCE BIOSCIENCES, INC. SPRB view →
2022-10-24 SC Milestone Pharmaceuticals Inc. MIST view →
2022-10-03 SC LAVA Therapeutics NV view →
2022-09-26 SC Milestone Pharmaceuticals Inc. MIST view →
2022-08-18 SC Mirum Pharmaceuticals, Inc. MIRM view →
2022-07-15 SC Bolt Biotherapeutics, Inc. BOLT view →
2022-02-22 SC Morphic Holding, Inc. view →
2022-01-27 SC Reneo Pharmaceuticals, Inc. OKUR view →
2021-12-20 SC Cyteir Therapeutics, Inc. view →
2021-11-22 SC SPRUCE BIOSCIENCES, INC. SPRB view →
2021-11-22 SC Nkarta, Inc. NKTX view →
2021-11-22 SC Bolt Biotherapeutics, Inc. BOLT view →
2021-08-12 SC Morphic Holding, Inc. view →
Showing 20 of 34

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →